A new review reveals how focal adhesion kinase (FAK) acts as a central regulator of tumor progression and immune suppression ...
Investor's Business Daily on MSN
Spyre Therapeutics flies on Takeda-rivaling ulcerative colitis results
Spyre Therapeutics stock soared to a four-year high Monday on positive 12-week test results for its ulcerative colitis ...
Over its ten years, the company has built a portfolio of 45 actives, developed a strong innovation pipeline, and refined an approach that blends advanced science with deep market understanding ...
A new comprehensive review is shedding light on the expanding role of focal adhesion kinase (FAK) in cancer biology and its potential as a ...
Morning Overview on MSN
Nanoparticle therapy targets lung tumors and cancer-related muscle loss
A team at Oregon State University has engineered lipid nanoparticles that deliver messenger RNA to lung tumors while ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results